172 related articles for article (PubMed ID: 33568562)
21. Deepening of eyelid superior sulcus during topical travoprost treatment.
Yang HK; Park KH; Kim TW; Kim DM
Jpn J Ophthalmol; 2009 Mar; 53(2):176-179. PubMed ID: 19333704
[TBL] [Abstract][Full Text] [Related]
22. Intermittent blurred vision and trichomegaly due to latanoprost.
Woo TL; Francis IC
Clin Exp Ophthalmol; 2001 Aug; 29(4):272-3. PubMed ID: 11545432
[No Abstract] [Full Text] [Related]
23. Erlotinib-related keratopathy in a patient underwent laser in situ keratomileusis.
Kau HC; Tsai CC
Cutan Ocul Toxicol; 2016 Sep; 35(3):257-9. PubMed ID: 26340340
[TBL] [Abstract][Full Text] [Related]
24. Erlotinib-induced trichomegaly in a male patient with pancreatic cancer.
Saif MW; Gnanaraj J
Cutan Ocul Toxicol; 2010 Mar; 29(1):62-6. PubMed ID: 19954400
[TBL] [Abstract][Full Text] [Related]
25. Erlotinib-associated bilateral anterior uveitis: resolution with posterior sub-Tenon's triamcinolone without erlotinib cessation.
Kirkpatrick CA; Almeida DR; Hornick AL; Chin EK; Boldt HC
Can J Ophthalmol; 2015 Oct; 50(5):e66-7. PubMed ID: 26455982
[No Abstract] [Full Text] [Related]
26. A case of trichomegaly of the eyelashes and facial hypertrichosis induced by erlotinib (Tarceva).
Márquez G; Herrera-Acosta E; Vidal I; Galvany L; Iglesias M; Umbert P
Int J Dermatol; 2009 Jan; 48(1):97-8. PubMed ID: 19126063
[No Abstract] [Full Text] [Related]
27. Calls to suspend European sales of erlotinib for lung cancer.
Tanday S
Lancet Respir Med; 2016 Sep; 4(9):691. PubMed ID: 27492661
[No Abstract] [Full Text] [Related]
28. Successful treatment of non-small cell lung cancer with gefitinib after erlotinib-induced severe eyelid erosion: Two case reports.
Asai N; Ohkuni Y; Yamaguchi E; Kaneko N
J Cancer Res Ther; 2015; 11(3):653. PubMed ID: 26458639
[TBL] [Abstract][Full Text] [Related]
29. Eyelash hypertrichosis induced by topical latanoprost: 6-month follow-up study.
Stecchi G; Saccucci S; Molinari S; De Gregorio F
Acta Ophthalmol Scand Suppl; 2002; 236():56-7. PubMed ID: 12390146
[No Abstract] [Full Text] [Related]
30. Trichomegaly of the eyelashes after treatment with erlotinib in non-small cell lung cancer.
Carser JE; Summers YJ
J Thorac Oncol; 2006 Nov; 1(9):1040-1. PubMed ID: 17409992
[No Abstract] [Full Text] [Related]
31. Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib.
Braiteh F; Kurzrock R; Johnson FM
J Clin Oncol; 2008 Jul; 26(20):3460-2. PubMed ID: 18612164
[No Abstract] [Full Text] [Related]
32. Cyclosporin-induced trichomegaly of accessory lashes as a cause of ocular irritation.
Jayamanne DG; Dayan MR; Porter R
Nephrol Dial Transplant; 1996 Jun; 11(6):1159-61. PubMed ID: 8671990
[No Abstract] [Full Text] [Related]
33. Prostaglandin-Associated Periorbitopathy in Children and Young Adults with Glaucoma.
Kim JS; Blizzard S; Woodward JA; Leyngold IM; Liss J; Freedman SF
Ophthalmol Glaucoma; 2020; 3(4):288-294. PubMed ID: 33008561
[TBL] [Abstract][Full Text] [Related]
34. Duodenal Perforation Secondary to Erlotinib Therapy in a Patient With Non-Small Cell Lung Cancer.
Rafiullah ; Shah WS; Majid NA; Islam R
WMJ; 2017 Feb; 116(1):34-6. PubMed ID: 29099567
[TBL] [Abstract][Full Text] [Related]
35. Persistent hair growth during treatment with the EGFR inhibitor erlotinib.
Alexandrescu DT; Kauffman CL; Dasanu CA
Dermatol Online J; 2009 Mar; 15(3):4. PubMed ID: 19379648
[TBL] [Abstract][Full Text] [Related]
36. A prospective study of iridial pigmentation and eyelash changes due to ophthalmic treatment with latanoprost.
Chiba T; Kashiwagi K; Ishijima K; Furuichi M; Kogure S; Abe K; Chiba N; Tsukahara S
Jpn J Ophthalmol; 2004; 48(2):141-7. PubMed ID: 15060793
[TBL] [Abstract][Full Text] [Related]
37. Adverse periocular reactions to five types of prostaglandin analogs.
Inoue K; Shiokawa M; Higa R; Sugahara M; Soga T; Wakakura M; Tomita G
Eye (Lond); 2012 Nov; 26(11):1465-72. PubMed ID: 23037910
[TBL] [Abstract][Full Text] [Related]
38. Rapid onset of conjunctivitis associated with overdosing of erlotinib.
Sun P; Long J; Chen P; He Q; Gao X; Li S
J Clin Pharm Ther; 2018 Apr; 43(2):296-298. PubMed ID: 29069525
[TBL] [Abstract][Full Text] [Related]
39. Trichomegaly and scalp hair changes following treatment with erlotinib in pulmonary adenocarcinoma patients: A case report and literature review.
Zheng H; Zhang H; Zhang T; Wang Q; Hu F; Li B
Exp Ther Med; 2016 Sep; 12(3):1287-1292. PubMed ID: 27588051
[TBL] [Abstract][Full Text] [Related]
40. Tubulointerstitial nephritis associated with erlotinib therapy for lung cancer.
Cho SL; Lin WC; Chuang CA; Liao WY; Lai CF
Nephrology (Carlton); 2020 Sep; 25(9):730. PubMed ID: 32364270
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
